Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Científica da Faculdade de Medicina de Campos |
Texto Completo: | https://www.fmc.br/ojs/index.php/RCFMC/article/view/392 |
Resumo: | In the past few decades, coronavirus infections have posed a global threat to public health. The new coronavirus, SARS-CoV-2, which appeared in December 2019, took a few months to cause the outbreak of the new disease (COVID-19) declared a pandemic by the World Health Organization (WHO). SARS-CoV-2 spreads initially through the respiratory tract with lymphopenia and hypercytokininemia, characteristics of immune dysregulation. While many infected individuals may be asymptomatic or have upper respiratory symptoms, others develop interstitial pneumonia that can quickly follow up with respiratory failure and may progress to multiple organ failure. The purpose of this review was to present the molecular interactions of SARS-CoV-2 with host cells; point out cytopathic effects; assess the extent of immune dysregulation; reveal the immunological mechanisms associated with pulmonary and extrapulmonary pathogenesis and verify the influence of genetic markers of susceptibility and protection for COVID-19. The production of knowledge since the beginning of the pandemic about the immune response to SARS-CoV-2 points out that, in infected individuals, viral proliferation and tissue damage occur beyond the lung tissue. Among the systemic findings, lesion of the submucosal lymphatic tissue of the gastrointestinal tract, renal focal hemorrhages, edema and neuronal degeneration, degeneration of hepatocytes, cardiovascular, hematological, cutaneous and obstetric manifestations were demonstrated. However, the possibility of recurrent seasonal infections by coronavirus of different genotypes stimulating partial immune memory and favoring the predominance of mild cases of the disease, should be considered. |
id |
FMC-0_55b766b7dfa62538338d0570f11e9002 |
---|---|
oai_identifier_str |
oai:ojs.www.fmc.br:article/392 |
network_acronym_str |
FMC-0 |
network_name_str |
Revista Científica da Faculdade de Medicina de Campos |
repository_id_str |
|
spelling |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 InfectionCONSIDERAÇÕES IMUNOLÓGICAS SOBRE A PATOGENIA DA INFECÇÃO PELO SARS-COV-2imunopatologiacitocinasextrapulmonarSARS-CoV-2COVID-19SARS-CoV-2COVID-19immunopathologycytokinesextrapulmonaryIn the past few decades, coronavirus infections have posed a global threat to public health. The new coronavirus, SARS-CoV-2, which appeared in December 2019, took a few months to cause the outbreak of the new disease (COVID-19) declared a pandemic by the World Health Organization (WHO). SARS-CoV-2 spreads initially through the respiratory tract with lymphopenia and hypercytokininemia, characteristics of immune dysregulation. While many infected individuals may be asymptomatic or have upper respiratory symptoms, others develop interstitial pneumonia that can quickly follow up with respiratory failure and may progress to multiple organ failure. The purpose of this review was to present the molecular interactions of SARS-CoV-2 with host cells; point out cytopathic effects; assess the extent of immune dysregulation; reveal the immunological mechanisms associated with pulmonary and extrapulmonary pathogenesis and verify the influence of genetic markers of susceptibility and protection for COVID-19. The production of knowledge since the beginning of the pandemic about the immune response to SARS-CoV-2 points out that, in infected individuals, viral proliferation and tissue damage occur beyond the lung tissue. Among the systemic findings, lesion of the submucosal lymphatic tissue of the gastrointestinal tract, renal focal hemorrhages, edema and neuronal degeneration, degeneration of hepatocytes, cardiovascular, hematological, cutaneous and obstetric manifestations were demonstrated. However, the possibility of recurrent seasonal infections by coronavirus of different genotypes stimulating partial immune memory and favoring the predominance of mild cases of the disease, should be considered.Nas últimas décadas, infecções por coronavírus representaram uma ameaça global à saúde pública. O novo coronavírus, SARS-CoV-2, que surgiu em Dezembro de 2019, levou poucos meses para provocar o surto da nova doença (COVID-19) declarada como pandemia pela Organização Mundial da Saúde (OMS). SARS-CoV-2 se dissemina, inicialmente, pelo trato respiratório com linfopenia e hipercitocinemia, características de desregulação imunitária. Enquanto muitos indivíduos infectados podem apresentar-se assintomáticos ou com sintomas respiratórios superiores, outros desenvolvem pneumonia intersticial que pode rapidamente seguir com insuficiência respiratória, podendo evoluir com falência de múltiplos órgãos. O propósito desta revisão consistiu em apresentar as interações moleculares do SARS-CoV-2 com células hospedeiras; assinalar os efeitos citopáticos; avaliar a extensão da desregulação imunológica; revelar os mecanismos imunológicos associados à patogênese pulmonar e extrapulmonar e verificar a influência de marcadores genéticos de suscetibilidade e de proteção para COVID-19. A produção de conhecimento desde o início da pandemia acerca da resposta imunitária ao SARS-CoV-2 aponta que, em indivíduos infectados, a proliferação viral e o dano tecidual ocorrem para além do tecido pulmonar. Dentre os achados sistêmicos foi demonstrado lesão do tecido linfático submucoso do trato gastrointestinal, hemorragias focais renais, edema e degeneração neuronal, degeneração de hepatócitos, manifestações cardiovasculares, hematológicas, cutâneas e obstétricas. No entanto, a possibilidade de infecções recorrentes sazonais por coronavírus de genótipos distintos estimularem memória imunitária parcial e favorecer o predomínio de casos brandos da doença, deve ser considerada.Faculdade de Medicina de Campos (FMC)2020-10-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/39210.29184/1980-7813.rcfmc.392.vol.15.n2.2020Scientific Journal of the Medical School of Campos; Vol. 15 No. 2 (2020): Edição COVID-19; 69-86Revista Científica da Faculdade de Medicina de Campos; v. 15 n. 2 (2020): Edição COVID-19; 69-861980-7813reponame:Revista Científica da Faculdade de Medicina de Camposinstname:Faculdade de Medicina de Campos (FMC)instacron:FMCporhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/392/219Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Camposhttps://creativecommons.org/licenses/by-sa/4.0info:eu-repo/semantics/openAccessCordeiro, Leonardo PessanhaCrespo, Isabel Ribeiro Gomes de QueirozFalcão, Maria Luisa BarcelosLeite, Yasmim de SouzaMagalhães, Isadora EnneSilva, Valmir Laurentino2021-01-11T12:21:01Zoai:ojs.www.fmc.br:article/392Revistahttps://www.fmc.br/ojs/index.php/RCFMC/PRIhttps://www.fmc.br/ojs/index.php/RCFMC/oai||revista@fmc.br1980-78131980-7813opendoar:2021-01-11T12:21:01Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)false |
dc.title.none.fl_str_mv |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection CONSIDERAÇÕES IMUNOLÓGICAS SOBRE A PATOGENIA DA INFECÇÃO PELO SARS-COV-2 |
title |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection |
spellingShingle |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection Cordeiro, Leonardo Pessanha imunopatologia citocinas extrapulmonar SARS-CoV-2 COVID-19 SARS-CoV-2 COVID-19 immunopathology cytokines extrapulmonary |
title_short |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection |
title_full |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection |
title_fullStr |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection |
title_full_unstemmed |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection |
title_sort |
Immunological Considerations on the Pathogenesis of SARS-CoV-2 Infection |
author |
Cordeiro, Leonardo Pessanha |
author_facet |
Cordeiro, Leonardo Pessanha Crespo, Isabel Ribeiro Gomes de Queiroz Falcão, Maria Luisa Barcelos Leite, Yasmim de Souza Magalhães, Isadora Enne Silva, Valmir Laurentino |
author_role |
author |
author2 |
Crespo, Isabel Ribeiro Gomes de Queiroz Falcão, Maria Luisa Barcelos Leite, Yasmim de Souza Magalhães, Isadora Enne Silva, Valmir Laurentino |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Cordeiro, Leonardo Pessanha Crespo, Isabel Ribeiro Gomes de Queiroz Falcão, Maria Luisa Barcelos Leite, Yasmim de Souza Magalhães, Isadora Enne Silva, Valmir Laurentino |
dc.subject.por.fl_str_mv |
imunopatologia citocinas extrapulmonar SARS-CoV-2 COVID-19 SARS-CoV-2 COVID-19 immunopathology cytokines extrapulmonary |
topic |
imunopatologia citocinas extrapulmonar SARS-CoV-2 COVID-19 SARS-CoV-2 COVID-19 immunopathology cytokines extrapulmonary |
description |
In the past few decades, coronavirus infections have posed a global threat to public health. The new coronavirus, SARS-CoV-2, which appeared in December 2019, took a few months to cause the outbreak of the new disease (COVID-19) declared a pandemic by the World Health Organization (WHO). SARS-CoV-2 spreads initially through the respiratory tract with lymphopenia and hypercytokininemia, characteristics of immune dysregulation. While many infected individuals may be asymptomatic or have upper respiratory symptoms, others develop interstitial pneumonia that can quickly follow up with respiratory failure and may progress to multiple organ failure. The purpose of this review was to present the molecular interactions of SARS-CoV-2 with host cells; point out cytopathic effects; assess the extent of immune dysregulation; reveal the immunological mechanisms associated with pulmonary and extrapulmonary pathogenesis and verify the influence of genetic markers of susceptibility and protection for COVID-19. The production of knowledge since the beginning of the pandemic about the immune response to SARS-CoV-2 points out that, in infected individuals, viral proliferation and tissue damage occur beyond the lung tissue. Among the systemic findings, lesion of the submucosal lymphatic tissue of the gastrointestinal tract, renal focal hemorrhages, edema and neuronal degeneration, degeneration of hepatocytes, cardiovascular, hematological, cutaneous and obstetric manifestations were demonstrated. However, the possibility of recurrent seasonal infections by coronavirus of different genotypes stimulating partial immune memory and favoring the predominance of mild cases of the disease, should be considered. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-10-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/392 10.29184/1980-7813.rcfmc.392.vol.15.n2.2020 |
url |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/392 |
identifier_str_mv |
10.29184/1980-7813.rcfmc.392.vol.15.n2.2020 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/392/219 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
dc.source.none.fl_str_mv |
Scientific Journal of the Medical School of Campos; Vol. 15 No. 2 (2020): Edição COVID-19; 69-86 Revista Científica da Faculdade de Medicina de Campos; v. 15 n. 2 (2020): Edição COVID-19; 69-86 1980-7813 reponame:Revista Científica da Faculdade de Medicina de Campos instname:Faculdade de Medicina de Campos (FMC) instacron:FMC |
instname_str |
Faculdade de Medicina de Campos (FMC) |
instacron_str |
FMC |
institution |
FMC |
reponame_str |
Revista Científica da Faculdade de Medicina de Campos |
collection |
Revista Científica da Faculdade de Medicina de Campos |
repository.name.fl_str_mv |
Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC) |
repository.mail.fl_str_mv |
||revista@fmc.br |
_version_ |
1798042302028972032 |